Zobrazeno 1 - 10
of 2 858
pro vyhledávání: ''
Autor:
Carlos E. Bueso-Ramos, Kelly K. Hunt, Roberto N. Miranda, Martha Romero, Adrian A. Carballo-Zarate, Carlos Ortiz-Hidalgo, Roberta Demichelis, Michael Misialek, Chi Young Ok, Claudia Recavarren, Mark W. Clemens, Qinglong Hu, Hun J. Lee, Mario L. Marques-Piubelli, Jie Xu, Angela Morine, Sergio Pina-Oviedo, Mitual Amin, Huan You Wang, Mark G. Evans, Aliyah R. Sohani, Swaminathan P. Iyer, L. Jeffrey Medeiros
Publikováno v:
Modern Pathology. 34:2148-2153
Breast implant-associated anaplastic large cell lymphoma (ALCL) is a distinctive type of T-cell lymphoma that arises around textured-surface breast implants. In a subset of patients, this disease can involve surrounding tissues, spread to regional ly
Publikováno v:
Ophthalmology Retina. 5:975-980
Purpose To examine the effect of delay in care on visual acuity (VA) in patients requiring intravitreal injections (IVIs). Design Retrospective cohort study. Participants Patients 18 years of age or older with diabetic macular edema (DME), proliferat
Autor:
Giovanni Pierorazio, Francesco Pavese, Giampiero Porzio, Katia Cannita, V. Cocciolone, Lucilla Verna, Silvia Rotondaro, Corrado Ficorella, Tina Sidoni, Alessandro Parisi
Publikováno v:
Breast Disease. 40:257-262
BACKGROUND: Despite the increase in chances of cure for early breast cancer (EBC) patients, approximately 20–45% of them will experience a disease recurrence, particularly bone metastases in 60–80% of cases, which occur more frequently in luminal
Autor:
Vuong Nguyen, Caroline C W Klaver, Frank D. Verbraak, Mark C Gillies, Daniel Barthelmes, Dirk L Ponsioen, Odette A. M. Tigchelaar-Besling
Publikováno v:
Acta Ophthalmologica (2008), 99, 6, pp. e884-e892
Acta Ophthalmologica, 99(6), e884-e892. Wiley-Blackwell Publishing Ltd
Acta Ophthalmologica
Acta Ophthalmologica (2008), 99, e884-e892
Acta Ophthalmologica, 99(6), e884-e892. Wiley-Blackwell Publishing Ltd
Acta Ophthalmologica
Acta Ophthalmologica (2008), 99, e884-e892
Contains fulltext : 238066.pdf (Publisher’s version ) (Open Access) PURPOSE: To compare treatment outcomes of treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) with bevacizumab as the first-line treatment, according to
Publikováno v:
Urology. 154:191-195
Objective To establish predictive factors of patients who failed intra-cavernosal injection therapy and ultimately required corporoglandular shunting during first-time ischemic priapism episodes. Methods A retrospective review was performed of all pa
Autor:
Bobby Paul, Maria Pikoula, A. K. Patwardhan, Abraham Olvera-Barrios, Andrew J. Lotery, A Davis, Vineeth Kumar, Salim Natha, Toks Akerele, Carolyn J.P. Jones, Usha Chakravarthy, Paul Taylor, Roy Schwartz, Haralabos Eleftheriadis, Sudeshna Patra, Christopher Brand, Peck-Lin Lip, Richard J Antcliff, Aaron Y. Lee, Alasdair Warwick, Geeta Menon, Faruque Ghanchi, U. Chakravarthy, Clare Bailey, Elizabeth Wilkinson, Sajjad Mahmood, Louise Downey, Raj Mukherjee, Catherine A Egan, Spiros Denaxas, James S Talks, Peck Lin Lip, Aires Lobo, Rehna Khan, Narendra Dhingra, Sheena George, Helen Palmer, Adnan Tufail
Publikováno v:
Ophthalmol Retina
PURPOSE: Management of neovascular age-related macular degeneration (nAMD) has evolved over the last decade with several treatment regimens and different medications. This study describes the treatment patterns and, importantly, visual outcomes over
Autor:
Nirav Patil, Ankit Mangla, Asrar Alahmadi, Nelroy Jones, Richard T. Lee, David L. Bajor, Jill S. Barnholtz-Sloan, Eva Selfridge, Amr Mohamed, Gino Cioffi, Aman Opneja, Tin-Yun Tang, Joel N. Saltzman
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4397-4404 (2021)
Cancer Medicine
Cancer Medicine
Background This study analyzes the pattern of use of single agent anticancer therapy (SAACT) in the treatment and survival of advanced hepatocellular carcinoma (aHCC) before and after sorafenib was FDA approved in 2007. Methods Adult patients diagnos
Autor:
Vy T. Ho, Elizabeth L. George, Jason T. Lee, Jordan R. Stern, Manuel Garcia-Toca, Kara A. Rothenberg
Publikováno v:
Journal of Vascular Surgery. 74:71-78
Thoracic endovascular aortic repair (TEVAR) is an effective treatment of blunt thoracic aortic injury (BTAI). However, the risks and benefits of administering intraoperative heparin in trauma patients are not well-defined, especially with regard to b
Autor:
Richard Greil, Armin Gerger, Renate Schaberl-Moser, Martin Pichler, Dominik A. Barth, Michael Stotz, Angela Djanani, Antonia Gantschnigg, Lena Horvath, Jakob M. Riedl, Herbert Stöger, Felix Renneberg, Konstantin Schlick, Christopher Rossmann, Florian Posch, Esther Schwarzenbacher, Florian Moik
Publikováno v:
European Journal of Cancer. 151:3-13
Background Gemcitabine/nab-paclitaxel (GN) and FOLFIRINOX are standard first-line treatment options for advanced pancreatic ductal adenocarcinoma (aPDAC), but currently no prospective randomised head-to-head comparison between these treatments has ye
Autor:
Diana Saravia, Andrew J. Plodkowski, Annapaola Mariniello, Benjamin Besse, Lizza E.L. Hendriks, Maria Lucia Reale, Fabrizio Tabbò, Gilberto Lopes, Lydie Cassard, Anne-Marie C. Dingemans, Kathryn C. Arbour, Matthew D. Hellmann, Margarita Majem, Hira Rizvi, Edouard Auclin, Jeffrey Girshman, Silvia Novello, M. Naigeon, Simona Carnio, Nathalie Cozic, F. Blanc-Durand, Laura Mezquita, Clarisse Audigier-Valette, Peter Sawan, Paolo Bironzo, Nathalie Chaput, Jose Carlos Ruffinelli, Luis Paz-Ares, Patricia Martin-Romano, Ernest Nadal, Melinda Charrier, Wungki Park, Isabel Ruth Preeshagul, David Planchard, Santiago Ponce, Gérard Zalcman, Caroline Rossoni
Publikováno v:
EUROPEAN JOURNAL OF CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
European Journal of Cancer, 151, 211-220. ELSEVIER SCI LTD
European Journal of Cancer, 151, 211-220. Elsevier Ltd.
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
European Journal of Cancer, 151, 211-220. ELSEVIER SCI LTD
European Journal of Cancer, 151, 211-220. Elsevier Ltd.
Background: dNLR at the baseline (B), defined by neutrophils/[leucocytes-neutrophils], correlates with immune-checkpoint inhibitor (ICI) outcomes in advanced non-small-cell lung cancer (aNSCLC). However, dNLR is dynamic under therapy and its longitud